ArticleFrontiers in endocrinology2026
Relationship between apolipoprotein M levels and diabetic retinopathy in patients with type 2 diabetes mellitus.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Apolipoprotein M (apoM) is a biologically important protein that facilitates the mobilization and transport of cholesterol and other bioactive molecules in circulation. This study aims to explore the association between plasma apolipoprotein M (apoM) levels and diabetic retinopathy in patients with type 2 diabetes mellitus (T2DM). This cross-sectional study included 339 patients with T2DM. Patients with diabetic retinopathy exhibited greater median plasma apoM levels than those without diabetic retinopathy (26.05 [21.09-30.37] mg/L vs. 21.47 [18.00-26.38] mg/L;
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.